Skip to main content

Alexander Hecht

Executive Vice President & Director of Operations

AHecht@mlstrategies.com

+1.202.434.7333

Follow:
Share:

Alex Hecht, Executive Vice President & Director of Operations at ML Strategies in Washington, DC, is a trusted attorney and policy strategist with over 20 years of experience shaping federal legislation and regulation. Drawing on deep relationships within Congress, federal agencies, and trade associations, he represents clients across a broad range of industries on how to navigate complex policy environments. 

Alex’s strategic insight and hands-on experience in both legislative and regulatory arenas empower clients to advance their priorities with clarity and confidence in an evolving policy landscape. Alex assists clients with their legislative and regulatory needs on a wide range of issues, including health care, technology, cybersecurity & privacy, energy, and federal procurement.  He specializes in assisting businesses off all sizes, with a focus on early- to mid-size small businesses.   He is an expert on small business access to capital and also federal non-dilutive funding programs, including the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.  

Prior to joining ML Strategies, Alex served for more than ten years in senior roles on Capitol Hill and in industry groups, including as Chief Counsel to then Senator Olympia J. Snowe (R-ME) on the Senate Committee on Small Business & Entrepreneurship. In that role, he led legislative efforts on health care, ERISA, tax incentives, and regulatory reform, contributing to landmark legislation such as the Affordable Care Act and the SHOP Act. He also worked closely with the Senate Commerce, Finance, and Homeland Security Committees, and developed legislation to reduce regulatory burdens on business. Alex has previously held legal and policy roles at the National Multi Housing Council and the Maryland Office of the Attorney General. A former freelance journalist who was published in Texas Monthly magazine, Alex was also the chief articles editor for the Houston Journal of Health Law & Policy at the University of Houston Law Center. 

Alex, alongside other members of the ML Strategies team, contributes to a recurring thought leadership series, AI: The Washington Report, which offers insights and analysis on federal policy developments, legislative trends, and regulatory actions related to artificial intelligence.

Education

  • George Washington University (LLM)
  • University of Houston Law Center (JD)
  • University of Texas - Austin (BA)

Recognition & Awards

  • JD Supra Readers’ Choice Award, Top Author – Artificial Intelligence, 2025 

  • JD Supra Readers' Choice Awards: a Top Author on the Affordable Care Act (2016)

  • Champion of Small Business Innovation: "For Exemplary work on behalf of America's SBIR Community" - Presented by Small Business Technology Council and National Small Business Association (2012)

  • The Council for Excellence in Government: Cutting the Red Tape Excellence Award

Case Studies

Case Study Hero Karl-Storz Mintz Case Study
On behalf of Karl Storz Endoscopy, ML Strategies has advocated for uniform federal regulation to protect patient safety before the FDA and with members of Congress — and defeated the digital right to repair from being implemented in Massachusetts.

Recent Insights

Events

Viewpoints

Viewpoint Thumbnail

Federal Response to COVID-19

March 16, 2020| Alert

Read about the federal government’s response to COVID-19, including $8B in emergency funding and the Families First Coronavirus Response Act pending in the House.
Viewpoint Thumbnail

2020 Congressional Highlights

January 15, 2020| Advisory

Viewpoint Thumbnail
This week, Congress is working towards passage of a continuing resolution that would fund the government through the middle of November. This will give policymakers and appropriators enough time to hash out differences in funding priorities as well as work on policies addressing drug pricing, surprise billing, and funding for public health programs. The surprise billing issue is really heating up with outside stakeholder groups weighing in and Congress carefully considering its next steps
Viewpoint Thumbnail
This article covers key Congressional cybersecurity initiatives, including the National Defense Authorization Act and House and Senate cybersecurity bills, as well as DoD and GAO reports on cybersecurity risks.
Viewpoint Thumbnail
Read about DHS’s Final EB-5 Regulations that will take effect on November 21, 2019, including a new standard minimum investment amount of $1.8 million.
Viewpoint Thumbnail
This week, the Affordable Care Act (ACA) is back in the news with oral arguments set to begin before the U.S. Court of Appeals for the Fifth Circuit. The court will decide whether to uphold a federal district court's ruling that struck down the ACA. This case has the potential to reshape the political landscape in 2020 if it reaches the Supreme Court. On Capitol Hill, policymakers are working hard to bring forth a drug pricing package before the August recess
Viewpoint Thumbnail
This week, the House is poised to take action on drug pricing by passing two pieces of legislation. As the House moves the bills through final passage, focus will shift to the Senate, which will unveil a legislative package around lowering costs for consumers in the coming weeks. The scope of this package is still unclear, but it should include a number of proposals that could pass on a bipartisan basis. We cover this and more in this week's preview, which you can find by clicking here.
Viewpoint Thumbnail
Following the two week recess, Congress is back in session and will have several high profile hearings this week. For starters, the Energy & Commerce Health subcommittee will continue reviewing prescription drug costs, this time focusing in on Medicare. In the Rules Committee, which does not typically host high profile hearings, they will hold the first committee hearing on H.R. 1384, one of the "Medicare for All" proposals. 
Viewpoint Thumbnail
This week, Congress will continue to look at lowering health costs. The House has been focused on both drug costs and overall health care costs, advancing packages to strengthen the individual market in addition to a series of bipartisan drug pricing bills.
Congress has continued its 57-year tradition of passing an annual defense authorization bill with the John S. McCain National Defense Authorization Act (NDAA) for Fiscal Year 2019 finalized by Congress on August 1 and signed into law by President Trump on August 13. The NDAA makes important reforms and updates to the process by which investments in U.S. businesses by foreign persons are reviewed by the Committee on Foreign Investment in the United States (CFIUS) and updates and codifies Department of Commerce practices related to export controls.

News & Press

Events

Moderator
Oct
26
2023

A Conversation with Governor Bill Weld

Mintz Toronto Office (200 Bay St, South Tower Suite 2800 Toronto, ON M5J 2J3)

Speaker
Moderator
Jun
19
2019

Health Care & Cybersecurity: A Powerful Combination

Mintz, ML Strategies, & Zingbox

Washington, DC

May
17
2016